BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16394360)

  • 1. Fatal disseminated strongyloidiasis in patients on immunosuppressive therapy: report of two cases.
    Reddy IS; Swarnalata G
    Indian J Dermatol Venereol Leprol; 2005; 71(1):38-40. PubMed ID: 16394360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disseminated strongyloidiasis complicating glioblastoma therapy: a case report.
    Aregawi D; Lopez D; Wick M; Scheld WM; Schiff D
    J Neurooncol; 2009 Sep; 94(3):439-43. PubMed ID: 19333553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strongyloidiasis complicating immunosuppression for pemphigus vulgaris.
    Walker SL; Mann TA
    Br J Dermatol; 2013 Dec; 169(6):1363-4. PubMed ID: 23855642
    [No Abstract]   [Full Text] [Related]  

  • 4. Fatal cutaneous Strongyloidiasis as a side effect of Pemphigus foliaceus treatment with mycophenolate mofetil.
    Vitiello M; Shelling M; Camacho I; Milikowski C; Kerdel FA
    J Drugs Dermatol; 2011 Apr; 10(4):418-21. PubMed ID: 21455554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disseminated Strongyloidiasis.
    Mileo Bacelar Guerreiro F; Tavares Sodré C; Brandão Pavan L; Feijó Barroso P; Carvalho Quintella D; Cuzzi T; Ramos-E-Silva M
    Acta Dermatovenerol Croat; 2018 Dec; 26(4):333-336. PubMed ID: 30665485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disseminated strongyloidiasis in immunocompromised patients--report of three cases.
    Galimberti R; Pontón A; Zaputovich FA; Velasquez L; Galimberti G; Torre A; Kowalczuk A
    Int J Dermatol; 2009 Sep; 48(9):975-8. PubMed ID: 19702983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Death caused by strongyloides hyperinfection in a leprosy patient on treatment for a type II leprosy reaction.
    Leang B; Lynen L; Tootill R; Griffiths S; Monchy D
    Lepr Rev; 2004 Dec; 75(4):398-403. PubMed ID: 15682976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lymphoma and pruritus: search for parasites].
    Gétaz L; Mezger N; Piguet V; Dietrich PY; Favet L
    Rev Med Suisse; 2009 May; 5(204):1112-4. PubMed ID: 19580208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Respiratory distress and purpura in an immunocompromised patient: hyperinfestation with dissemination of Strongyloides stercoralis].
    Esteve-Martínez A; Sánchez-Carazo JL; Alegre-de-Miquel V
    Med Clin (Barc); 2013 Dec; 141(11):512. PubMed ID: 23790586
    [No Abstract]   [Full Text] [Related]  

  • 10. Strongyloidiasis: challenges in diagnosis and management in non-endemic Kuwait.
    Hira PR; Al-Ali F; Shweiki HM; Abdella NA; Johny M; Francis I; Iqbal J; Thompson R; Nevar F
    Ann Trop Med Parasitol; 2004 Apr; 98(3):261-70. PubMed ID: 15119971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening of immunocompromised patients at risk of strongyloidiasis in western Turkey using ELISA and real-time PCR.
    Erdem Kivrak E; Atalay Şahar E; Can H; Döşkaya M; Yilmaz M; Pullukçu H; Caner A; Töz H; Gürüz AY; Işikgöz Taşbakan M
    Turk J Med Sci; 2017 Jun; 47(3):897-901. PubMed ID: 28618740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strongyloides stercoralis hyperinfection in hematopoietic stem cell transplantation.
    Wirk B; Wingard JR
    Transpl Infect Dis; 2009 Apr; 11(2):143-8. PubMed ID: 19144095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disseminated strongyloidiasis in a child with lymphoblastic lymphoma.
    Daubenton JD; Buys HA; Hartley PS
    J Pediatr Hematol Oncol; 1998; 20(3):260-3. PubMed ID: 9628440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatal Strongyloides stercoralis hyperinfection diagnosed by Papanicolaou-stained sputum smears.
    Sidoni A; Polidori GA; Alberti PF; Scionti L
    Pathologica; 1994 Feb; 86(1):87-90. PubMed ID: 8072809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strongyloides hyperinfection syndrome--an unappreciated opportunistic infection.
    Sekhar U; Madan M; Ranjitham M; Abraham G; Eapen G
    J Assoc Physicians India; 2000 Oct; 48(10):1017-9. PubMed ID: 11200903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Disseminated strongyloidiasis].
    Nozais JP; Thellier M; Datry A; Danis M
    Presse Med; 2001 Apr; 30(16):813-8. PubMed ID: 11388155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disseminated strongyloidiasis: a retrospective study of clinical course and outcome.
    Lam CS; Tong MK; Chan KM; Siu YP
    Eur J Clin Microbiol Infect Dis; 2006 Jan; 25(1):14-8. PubMed ID: 16418832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal strongyloidiasis: a diagnosis frequently missed in the tropics.
    Agrawal V; Agarwal T; Ghoshal UC
    Trans R Soc Trop Med Hyg; 2009 Mar; 103(3):242-6. PubMed ID: 18804829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disseminated strongyloidiasis with cutaneous manifestations in an immunocompromised host.
    Gordon SM; Gal AA; Solomon AR; Bryan JA
    J Am Acad Dermatol; 1994 Aug; 31(2 Pt 1):255-9. PubMed ID: 8040411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disseminated Strongyloides stercoralis in AIDS: a report from India.
    Satyanarayana S; Nema S; Kalghatgi AT; Mehta SR; Rai R; Duggal R; Bhardwaj JR
    Indian J Pathol Microbiol; 2005 Oct; 48(4):472-4. PubMed ID: 16366097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.